Search
Search Funnelback University
- Refined by:
- Date: 2022
1 -
50 of
183
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
New Head at Cambridge Enterprise Seed Funds – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/new-head-at-cambridge-enterprise-seed-funds/6 Apr 2022: Christine starts her new role having successfully raised £30 million of new investment from the University of Cambridge. ... I know she will bring real expertise and energy to our new programming vision. -
Academic consultancy services – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/be-a-consultant/22 Mar 2022: Academic consultancy is a key way in which the University shares its knowledge and expertise with government, industry and the public sector. -
Dr Amanda Zeffman - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/team/dr-amanda-zeffman/20 Oct 2022: In 2017-18, Amanda’s team saw a 63% increase in the number of new consultants with deals signed for 165 academics and 234 clients in that period. -
Academic Consultancy at the University of Cambridge
https://www.enterprise.cam.ac.uk/video/academic-consultancy/7 Jul 2022: If you are a University of Cambridge academic or researcher and have been approached by an organisation to be a paid consultant, we can help -
Bamboo cricket bats – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/bamboo-bats/7 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 7 May 2022. Bamboo cricket bats. Share:. Bamboo bats… Howzat? Willow has had a good innings but cricket bats should now be made from bamboo, Cambridge researchers argue. Bamboo -
Storm Therapeutics: targeting cancer – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/targeting-cancer/25 Jan 2022: Case study on Storm Therapeutics, a discovery and development company targeting enzymes that modify RNA using small molecules. -
Apollo Therapeutics: KE Award Winners – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/apollo-therapeutics-ke-award-winners/1 Mar 2022: Apollo Therapeutics will continue collaborating with partner universities to source new projects, meaning this deal may supercharge knowledge exchange and impact into the future. ... It creates the opportunity to unlock new jobs, support larger-scale R&D, -
Queen's Birthday Honours 2022 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/queens-birthday-honours-2022/2 Jun 2022: She is, along with Dr Sai Shivareddy, co-founder of Nyobolt, pioneering a new class of battery technology that achieves record-breaking ultra-fast charging and supports the transition to a -
New approach to ‘cosmic magnet’ manufacturing could reduce reliance…
https://www.enterprise.cam.ac.uk/new-approach-to-cosmic-magnet-manufacturing-could-reduce-reliance-on-rare-earths-in-low-carbon-technologies/25 Oct 2022: 25 October 2022. New approach to ‘cosmic magnet’ manufacturing could reduce reliance on rare earths in low-carbon technologies. ... Researchers have discovered a potential new method for making the high-performance magnets used in wind turbines and -
Influenza PR-8 Antibodies - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/influenza-pr-8-antibodies/9 May 2022: Mouse monoclonal antibodies raised against Influenza PR-8 developed at the University of Cambridge. -
Creative Cambridge Annual Conference Returns – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/creative-cambridge-annual-conference-returns/17 Aug 2022: Selen Etingu-Breslaw’s announcement of the new round of Creative Encounters funding and support to seed collaborations between researchers and artists. ... We are glad to facilitate introductions and to devise more fora and events to make some new -
Powering a green revolution – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/powering-a-green-revolution/23 May 2022: WHAT? Based on Longobardi’s original research, Cambridge GaN Devices has developed a range of power devices using the energy-efficient semiconductor, gallium nitride (GaN), heralding a new era of greener -
Experts & Mentors Programme – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-external-organisations/experts-mentors-programme/29 Nov 2022: Gain insight into new and ground-breaking technologies and companies originating from the University of Cambridge. ... Get involved with new spin-out companies originating from the University of Cambridge. -
From sick-care to health-care – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/from-sick-care-to-health-care/9 Feb 2022: We are starting to trial it in some of these new areas with promising early results. ... And then we had the pandemic, which badly affected TumourVue. What do you find most difficult about starting a new venture? -
Celebrating University research to commercial reality – Cambridge…
https://www.enterprise.cam.ac.uk/celebrating-university-research-to-commercial-reality/30 Sep 2022: Online research and engagement platform THIScovery and new approaches for maternity care, presented by Professor Mary Dixon-Woods and Dr Helen Atkinson. -
The Chris Abell Postdoc Business Plan Competition 2022 – Cambridge…
https://www.enterprise.cam.ac.uk/events/the-chris-abell-postdoc-business-plan-competition-2022/3 May 2022: The Chris Abell Postdoc Business Plan Competition is a programme designed to help accelerate the creation of businesses from University research. -
Our Cambridge connections – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/beyond-the-university/25 Jan 2022: We nurture close connections and strong working relationships with a broad range of stakeholders in the wider Cambridge ecosystem. -
Science and Technology Facilities Council (STFC) Follow-on Fund (FoF) …
https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-follow-on-fund-fof/18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Follow-on Fund (FoF). FoF is designed to fund a short term proof-of-concept project, which could lead on to further commercial -
Can commercialisation lead to better impact outcomes for policy…
https://www.enterprise.cam.ac.uk/can-commercialisation-lead-to-better-impact-outcomes-for-policy-research/16 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing about ‘entrepreneurial’ pathways to impact as an alternative way -
New financing round for PneumaCare – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/pneumacare-completes-new-financing-round/1 Feb 2022: 1 August 2011. New financing round for PneumaCare. Share:. Cambridge Enterprise portfolio company PneumaCare Limited has completed a successful investment round of £2 million, led by new investor Sud Investments, together -
Challenges and Opportunities for Commercialisation of Research out of …
https://www.enterprise.cam.ac.uk/challenges-and-opportunities-for-commercialisation-of-research-out-of-the-social-sciences/25 Oct 2022: The push for commercialising research in the social sciences is relatively new compared to STEM subjects. ... Market-based solutions to address societal problems from academic research should not be presented as a new agenda. -
Develop a commercial opportunity – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/19 Jan 2022: become new areas of research for you. -
Impact Insight: Kalamna CIC – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/12 May 2022: Dr Khalil has spent her career researching how young Arabic learners can be engaged through a new approach to Arabic phonics. ... A licensing arrangement managed by Cambridge Enterprise now enables Kalamna CIC to launch the toolkit to an international -
NMC coating information sheet (Gre-7694-20)
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf9 Feb 2022: Professor Dominic Wright leads internationally-respected research into new synthetic routes to a broad range of main group and transition metal compounds. -
Centessa Pharmaceuticals – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/11 Apr 2022: 16 February 2022. Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant. ... The new company was launched with $250 million in Series A financing—one of the biggest in recent years—led by blue-chip investors. -
Murid herpesvirus-4 (MuHV 4) Antibodies - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/murid-herpes-virus-4-antibodies/9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge. -
CRoSS Programme: Research Impact Ideation Workshop – Cambridge…
https://www.enterprise.cam.ac.uk/events/cross-programme-research-impact-ideation-workshop-2/2 Dec 2022: Join an engaged and action-focussed community as we explore new models for social science impact on global challenges. -
Cambridge Enterprise licenses unique new device for cancer diagnosis…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licences-unique-new-device-for-cancer-diagnosis/15 Nov 2022: 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. -
The University of Cambridge ecosystem – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/within-the-university/20 Jul 2022: i-Teams. The i-Teams innovation programme brings together multi-disciplinary teams of post-graduates with industry mentors and real Cambridge inventions to assess the commercial viability of new technologies and ... We currently run 2 courses a term, -
Impact Insight: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-ikva/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to -
Science and Technology Facilities Council (STFC) Knowledge Exchange…
https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-knowledge-exchange-and-commercialisation-kec-fellowships/18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of -
DIOSynVax: tackling COVID-19 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/11 Apr 2022: Historically, the creation of an effective new vaccine has required years of work and hundreds of millions of pounds. -
CAM2 software for hearing aid fitting – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/9 May 2022: CAM2 has been developed to provide a superior solution for the tailoring of wide-band hearing aid parameters using the audiogram alone, and is an essential new tool in the audiology -
New Head at Cambridge Enterprise Seed Funds | University of Cambridge
https://www.enterprise.cam.ac.uk/news/new-head-at-cambridge-enterprise-seed-funds/7 Apr 2022: Search. Search. New Head at Cambridge Enterprise Seed Funds. News. New Head at Cambridge Enterprise Seed Funds.. ... This news story was first published on Cambridge Enterprise's website on 06 April 2022. -
Research tools licensing – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process. -
Impact Insight: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-xampla/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research -
Impact Ideation Workshop: Global Sustainable Development Monday 28th…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/2022.11.23_AHSS-QA-Maryam-Tanwir_Web.pdf2 Dec 2022: But unfortunately the minute that there was a change in government, the new government cut off all funding and the project was in disarray. -
Impact Insight video case study: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/15 Mar 2022: The first in our new series of Impact Insight videos focuses on Xampla. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external -
KARPAS 25 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
The Carbon Challenge: Daily Decarbonisation – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/carbon-challenge-2022/28 Jan 2022: For news on upcoming Carbon Challenge events and how to register, visit our Events pages. -
Creative Cambridge 2022 highlights – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/creative-cambridge-2022-highlights/18 Aug 2022: With themes of Content, Collections and Community, Creative Impact, and Creative Innovation, the day featured great speakers, inspirational panels, demos, pitches and of course conversation designed to spark new ideas and ... More on Creative Cambridge. -
KARPAS 417 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
Impact Insight video case study: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-versed-ai/15 Mar 2022: Impact Insight video case study: Versed AI. The second in our new series of Impact Insight videos focuses on Versed AI. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations -
Realising the market potential of software – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/realising-the-market-potential-of-software/18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions. -
New grafting technique published in Nature - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/research-supported-by-cambridge-enterprise-and-ceres-agri-tech-published-in-nature/16 Mar 2022: Share:. New grafting technique could combat the disease threatening Cavendish bananas. ... Grafting genetically different root and shoot tissues can result in a plant with new traits – ranging from dwarf shoots, to pest and disease resistance. -
Impact Insight: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-versed-ai/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation -
Research Report Commercialisation and Policy Research Authors: Dr…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/Roundtable-report_Commercialisation_PolicyResearch.pdf15 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing. ... The above reduces the possibilities that usually originate from -
KARPAS 929 Human Myeloma cell line - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/karpas-929-human-myeloma-cell-line/9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research. -
Impact Insight video case study: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-ikva/23 Mar 2022: Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external organisation looking for new -
Watch our #nextgreatidea film – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/watch-our-nextgreatidea-film/15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.